The Center faculty come from all four UCSF schools and conduct research and teaching in every aspect of tobacco control, from efforts by the tobacco industry to manipulate international politics to the molecular biology of nicotine addiction.


Carolyn Calfee, MD, MAS

Assistant Professor of Medicine

Research focuses on the effects of active and passive smoking on susceptibility to acute lung injury, a major cause of respiratory failure in critically ill patients. In addition, she is interested in the use of biomarkers to measure cigarette smoke exposure.

Timothy Carmody, PhD

Clinical Professor

Dr. Carmody's work focuses on the treatment of nicotine dependence in adult chronic smokers. Dr. Carmody has several professional interests in the field of behavioral medicine, including treatment of nicotine dependence, chronic pain, behavioral factors in coronary heart disease, and obesity/weight management.  His primary interest is in the treatment of nicotine dependence in adult chronic smokers. 

Janine Cataldo, RN, PhD, FAAN

Physiological Nursing

Dr. Cataldo's research and clinical foci include: older adults’ risk perceptions of conventional, new and emerging  tobacco  products, and e- cigarettes, how these perceptions are affected by pro- and anti-tobacco messages; the impact of tobacco industry activities on older smokers and geriatric science; lung cancer stigma, symptom burden, and quality of life; and use of virtual worlds as an mHealth intervention to decrease lung cancer stigma and improve patient-clinician communication. Dr.

Benjamin Chaffee, DDS, MPH, PhD

Assistant Professor
Preventive & Restor Dent Sci

The overarching goal of our team’s epidemiologic research program is to understand how various behaviors, biological attributes, and social circumstances influence health and disease distributions, often inequitably, across populations. Application of such knowledge aims to inform future public health practices, health policies, and clinical guidelines that elevate the health of patients and vulnerable communities, both locally and worldwide.

Jing Cheng, MD, MS, PhD

Adjunct Professor
Preventive & Restor Dent Sci

Dr. Cheng earned her medical degree in China, M.S. in nutrition at Cornell University in 2002, and Ph.D. in biostatistics at the University of Pennsylvania in 2006. Before joining UCSF School of Dentistry in 2010, Dr. Cheng was an Assistant Professor in Biostatistics at the University of Florida’s College of Medicine.

Robin Corelli, PharmD

Clinical Pharmacy

Primary interest in tobacco cessation education and training. Dr. Corelli has co-coordinated, with other Tobacco Center members (Drs. Hudmon and Kroon), a comprehensive tobacco cessation training program, Rx for Change: Clinician-Assisted Tobacco Cessation, for students in the health professions.

Eric Crosbie, PhD

Postdoctoral Scholar
Cardiovascular Research Inst

Eric Crosbie recently received his PhD in Politics at the University of California, Santa Cruz (UCSC).

Kevin Delucchi, PhD

Professor in Residence

Dr. Delucchi is a quantitative expert specializing in psycho-social research. Dr. Delucchi's work focuses on statistical methods for analysis of quantitative data including clinical trials of treatments for smoking cessation. He has collaborated with numerous investigators on nicotine-related research and is a member of an NIH Study Section.

Stuart Gansky, MS, DrPH

Professor, School of Dentistry
Preventive & Restor Dent Sci

My research concentrates on oral health research, health disparities research, applied statistical analyses and related method­ological issues. Balancing these components is essential to successful and practical oral epidemiology research. Methodological examination helps ground health research and build convincing argu­ments, while collaborative health research generates opportunities for innovative statistical practice and provides challenges for developing ways to solve real world problems

Peter Ganz

Chief, Cardiology/SFGH

Dr. Ganz is the Chief of Cardiology and the Director of the Center of Excellence in Vascular Research at the San Francisco General Hospital. He is the Maurice Eliaser Distinguished Professor of Medicine at the University of California, San Francisco. Dr. Ganz has been a pioneer and a leader in translational vascular research. He has focused on understanding key elements of human atherosclerosis including the pathobiology of the human endothelium, the biology of vascular nitric oxide, systemic and vascular inflammatory responses and atherosclerotic plaque instability.

Stanton Glantz, PhD

Professor of Medicine

RESEARCH INTERESTS: Dr. Glantz, the Truth Initiative Distinguished Professor of Tobacco Control, conducts research on a wide range of topics ranging from the health effects of secondhand smoke (with particular emphasis on the cardiovascular system) to the efficacy of different tobacco control policies. As the tobacco landscape has changed, Dr. Glantz' work has expanded to include e-cigarettes and marijuana, both of which are expanding the tobacco epidemic.

Warren Gold, MD

Professor of Medicine

Major academic activities include clinical research programs, training in systems physiology, supervision of the Adult Pulmonary Laboratories, consulting with industry on systems physiology, including the effects of secondhand smoke on lung function. After internal medicine and chief medical residency at the Beth Israel Hospital in Boston (1959-62), he received his research training at the Cardiovascular Research Institute, UCSF with Jay A. Nadel and Julius H.